+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Japanese monkey (Macaca fuscata) with alveolar echinococcosis after treatment with albendazole for 10 years: serodiagnosis and determination of albendazole metabolites



Japanese monkey (Macaca fuscata) with alveolar echinococcosis after treatment with albendazole for 10 years: serodiagnosis and determination of albendazole metabolites



Parasitology Research 106(1): 69-74



In 1997, an outbreak of alveolar echinococcosis in Japanese monkeys (Macaca fuscata) occurred in a zoo in Hokkaido, Japan. Twelve infected monkeys from a colony (n = 57) were diagnosed serologically by Western blotting, and ultrasonography showed the presence of tumor-like tissue in the livers of nine monkeys. The 12 infected monkeys have been treated with albendazole for 10 years without surgical resection. Ten of these monkeys have died so far; diagnoses were confirmed histopathologically through autopsy. Two of these monkeys are still alive. Recently, a significant difference between the two living monkeys was recognized. A difference in curative effect was demonstrated between the two living monkeys by radiography, contrast enhanced computed tomography, and contrast ultrasound. One showed metastasis to various organs, and the other appeared to be almost cured, as demonstrated by size reduction and calcification of the lesion after albendazole treatment for 10 years. This time, serological reexamination was performed to corroborate this apparent difference. The serological tests supported the preliminary imaging findings. In addition, the presence of albendazole metabolites in sera was confirmed by high-performance liquid chromatography. In this study, it was demonstrated that tests which have been used in human cases were also effective for diagnosing alveolar echinococcosis and for assessing curative effects in nonhuman primates such as M. fuscata.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 054025635

Download citation: RISBibTeXText

PMID: 19756740

DOI: 10.1007/s00436-009-1627-2


Related references

Determination of two metabolites of albendazole, albendazole-sulfoxide and albendazole-sulfone in cow's milk using an HPLC method. A systematic approach to optimise extraction conditions. Chromatographia 48(11/12): 777-784, 1998

Therapeutic drug monitoring of albendazole: determination of albendazole, albendazole sulfoxide, and albendazole sulfone in human plasma using nonaqueous capillary electrophoresis. Electrophoresis 21(4): 729-736, 2000

A simple LC-MS/MS method to determine plasma and cerebrospinal fluid levels of albendazole metabolites (albendazole sulfoxide and albendazole sulfone) in patients with neurocysticercosis. Biomedical Chromatography 26(2): 267-272, 2012

Clinical effect and safety of liposomal-albendazole and tablet-albendazole for the treatment of human cystic echinococcosis. Zhonghua Gan Zang Bing Za Zhi 19(7): 532-536, 2012

LC-MS/MS method for simultaneous determination of diethylcarbamazine, albendazole and albendazole metabolites in human plasma: Application to a clinical pharmacokinetic study. Journal of Pharmaceutical and Biomedical Analysis 151: 84-90, 2018

Reversed-phase liquid chromatographic method with fluorescence detection for the simultaneous determination of albendazole sulphoxide, albendazole sulphone and albendazole 2-aminosulphone in sheep plasma. Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences 805(2): 267-274, 2004

Treatment of experimental alveolar echinococcosis with albendazole: A 1H NMR spectroscopic study. Canadian Journal of Zoology 75(2): 198-204, 1997

The pharmacokinetics of albendazole metabolites following administration of albendazole, albendazole sulfoxide and netobimin to one-month- and eight-month-old sheep. International Journal for Parasitology 25(10): 1207-1212, 1995

Efficacy of Albendazole-Chitosan Microsphere-based Treatment for Alveolar Echinococcosis in Mice. Plos Neglected Tropical Diseases 9(9): E0003950, 2016

In vivo effect of oral albendazole and albendazole sulphoxide on development of secondary echinococcosis in mice. International Journal for Parasitology 27(11): 1341-1345, 1998

Investigation on blood concentrations of albendazole sulfoxides in patients with cystic echinococcosis treated by emulsion albendazole. Endemic Diseases Bulletin 16(3): 64-66, 2001

Comparative Evaluation of Liposomal Albendazole and Tablet-Albendazole Against Hepatic Cystic Echinococcosis: A Non-Randomized Clinical Trial. Medicine 95(4): E2237, 2016

Alveolar echinococcosis: Em2plus-ELISA and Em18-western blots for follow-up after treatment with albendazole. Transactions of the Royal Society of Tropical Medicine and Hygiene 91(4): 476-478, 1997

Efficiency of liposomal albendazole for the treatment of the patients with complex alveolar echinococcosis: a comparative analysis of CEUS, CT, and PET/CT. Parasitology Research 114(11): 4175-4180, 2017

Albendazole in treatment of human cystic echinococcosis: 12 years of experience. Acta Tropica 64(1/2): 79-93, 1996